Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents

被引:171
|
作者
Baillie, GS [1 ]
Douglas, LJ [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
关键词
D O I
10.1128/AAC.42.8.1900
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A perfused biofilm fermenter, which allows growth-rate control of adherent microbial populations, was used to assess whether the susceptibility of Candida albicans biofilms to antifungal agents is dependent on growth rate. Biofilms were generated under conditions of glucose limitation and were perfused with drugs at a high concentration (20 times the MIG). Amphotericin B produced a greater reduction in the number of daughter cells in biofilm eluates than ketoconazole, fluconazole, or flucytosine, Similar decreases in daughter cell counts were observed when biofilms growing at three different rates were perfused with amphotericin B, In a separate series of experiments, intact biofilms, resuspended biofilm cells, and newly formed daughter cells were removed from the fermenter and were exposed to a lower concentration of amphotericin B for 1 h, The susceptibility profiles over a range of growth rates were then compared with those obtained for planktonic cells grown at the same rates under glucose limitation in a chemostat. Intact biofilms were resistant to amphotericin B at all growth rates tested, whereas planktonic cells were resistant only at low growth rates (less than or equal to 0.13 h(-1)). Cells resuspended from biofilms were less resistant than intact biofilm populations but more resistant than daughter cells; the susceptibilities of both these cell types were largely independent of growth rate. Our findings indicate that the amphotericin B resistance of C, albicans biofilms is not simply due to a low growth rate but depends on some other feature of the biofilm mode of growth.
引用
收藏
页码:1900 / 1905
页数:6
相关论文
共 50 条
  • [31] The effect of some antineoplastic and antifungal agents on Candida albicans in vitro.
    Enberg, N
    Salonen, J
    Issakainen, J
    Lenander-Lumikari, M
    [J]. JOURNAL OF DENTAL RESEARCH, 2000, 79 (05) : 1295 - 1295
  • [32] Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
    Shinde, Ravikumar B.
    Chauhan, Nitin M.
    Raut, Jayant S.
    Karuppayil, Sankunny M.
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2012, 11
  • [33] Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
    Ravikumar B Shinde
    Nitin M Chauhan
    Jayant S Raut
    Sankunny M Karuppayil
    [J]. Annals of Clinical Microbiology and Antimicrobials, 11
  • [34] Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms
    Holtappels, Michelle
    Swinnen, Erwin
    De Groef, Lies
    Wuyts, Jurgen
    Moons, Lieve
    Lagrou, Katrien
    Van Dijck, Patrick
    Kucharikova, Sona
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [35] In vitro activity of antifungal combinations against Candida albicans biofilms
    Tobudic, Selma
    Kratzer, Christina
    Lassnigg, Andrea
    Graninger, Wolfgang
    Presterl, Elisabeth
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 271 - 274
  • [36] In Vivo Antifungal Activity of Monolaurin against Candida albicans Biofilms
    Seleem, Dalia
    Freitas-Blanco, Veronica Santana
    Noguti, Juliana
    Zancope, Bruna Raquel
    Pardi, Vanessa
    Murata, Ramiro Mendonca
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (08) : 1299 - 1302
  • [37] Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans
    Watamoto, T.
    Samaranayake, L. P.
    Jayatilake, J. A. M. S.
    Egusa, H.
    Yatani, H.
    Seneviratne, C. J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (04) : 333 - 339
  • [38] In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms
    Miceli, Marisa H.
    Bernardo, Stella M.
    Lee, Samuel A.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (04) : 326 - 332
  • [39] Evolution of antifungal drug resistance in Candida albicans
    Morschhaeuser, J.
    [J]. MYCOSES, 2014, 57 : 18 - 18
  • [40] Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and impact of the MIC, growth rate, and resistance genotype on the antifungal effect
    Hope, William W.
    Warn, Peter A.
    Sharp, Andrew
    Howard, Susan
    Kasai, Miki
    Louie, Arnold
    Walsh, Thomas J.
    Drusano, George L.
    Denning, David W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3680 - 3688